Matt Luther, MD MSCI
@drjmluther.bsky.social
π€ 930
π₯ 582
π 125
Nephrologist, Hypertension specialist, Physician-scientist.
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
11 days ago
Chronotherapy in the news again?
@medscape.com
discusses the story so far with the new ONAM study
www.medscape.com/viewarticle/...
@drlabos.bsky.social
feat Scott Garrison and moi
#Hypertension
loading . . .
Are BP Meds More Effective if Taken at Night?
The OMAN trial reignited the debate on whether it makes a difference clinically if antihypertensives are taken in the morning or the evening. Cardiologist Chris Labos reviews the evidence.
https://www.medscape.com/viewarticle/rise-and-fall-and-rise-again-bp-chronotherapy-2025a1000t3a
1
7
1
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
about 2 months ago
Hypertension Secrets has been translated into multiple languages, including Lithuanian! Get your copy here:
shop.elsevier.com/books/hypert...
@edgarvlermamd.bsky.social
@drjmluther.bsky.social
1
9
2
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
3 months ago
The CPC from last
@ahascience.bsky.social
#HypertensionSessions
now published in
@ahajournals.bsky.social
www.ahajournals.org/doi/10.1161/...
thanks to
@drjmluther.bsky.social
and all the education editors for the invite We hope it makes for an educational read!
3
12
7
reposted by
Matt Luther, MD MSCI
Jordy Cohen
3 months ago
New 2025 AHA/ACC Hypertension Guideline dropped!
www.jacc.org/doi/10.1016/...
#hypertension
#medsky
#nephsky
loading . . .
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College o...
https://www.jacc.org/doi/10.1016/j.jacc.2025.05.007
5
24
13
reposted by
Matt Luther, MD MSCI
Albert and Mary Lasker Foundation
4 months ago
#LaskerLaureate
Rustom Jal Vakil was born
#OTD
in 1911. He won a
#LaskerAward
in 1957 for his studies on the use of reserpine in the treatment of
#hypertension
.
ow.ly/bFTR50FunRI
π§ͺ
loading . . .
Treatment of hypertension - Lasker Foundation
Explore All 1957 Winners & Awards > Rustom Jal VakilKing Edward VII Memorial Hospital, Bombay For studies on the use of reserpine in the treatment of hypertension. The story of Rauwolfiaβ¦
http://ow.ly/bFTR50FunRI
2
4
3
reposted by
Matt Luther, MD MSCI
Wanpen Vongpatanasin
4 months ago
New PA Endo guideline is also out by experts
@anandvaidya17.bsky.social
#Cardiosky
@hswapnil.medsky.social
doi.org/10.1210/clin...
loading . . .
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
AbstractBackground. Primary aldosteronism (PA), a primary adrenal disorder leading to excessive aldosterone production by one or both adrenal glands, is a
https://doi.org/10.1210/clinem/dgaf284
1
22
14
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
5 months ago
The first
#ERA25
simultaneous pub CONFIDENCE trial of empagliflozin + finerenone in N = 579 Greater reduction in ACR and BP Note the impressive GFR dip
www.nejm.org/doi/full/10....
4
40
24
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
5 months ago
Plenary at
@hypertensioncanada.bsky.social
with
@drjmluther.bsky.social
on new drugs He starts of with the really old drugs!
#CHC25
2
12
4
reposted by
Matt Luther, MD MSCI
Jordy Cohen
6 months ago
Phase 2 trial of the new antihypertensive agent, ultra-long-acting (q6 month), subq, small interfering RNA against angiotensinogen (Zilebesiran), hit JAMA! h/t
@drjmluther.bsky.social
jamanetwork.com/journals/jam...
1/
loading . . .
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
This randomized clinical trial examines the efficacy and safety of zilebesiran vs placebo when added to a standard antihypertensive medication in adult patients with uncontrolled hypertension.
https://jamanetwork.com/journals/jama/fullarticle/2834632
1
15
8
Matt Luther, Nephrologist/HTN specialist COI: Mineralys consulting
#NephJC
6 months ago
2
6
1
reposted by
Matt Luther, MD MSCI
Mineralys Therapeutics
6 months ago
Today we presented detailed results from our pivotal Ph3 Launch-HTN trial at
#ESH2025
, reinforcing the promise of lorundrostat as a new treatment approach for aldosterone driven
#hypertension
. Read our press release to learn more:
ir.mineralystx.com/news-events/...
$MLYS
#bloodpressure
0
3
3
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
6 months ago
There you have it: BEDMED published in
@jama.com
jamanetwork.com/journals/jam...
h/t
@drjmluther.bsky.social
No difference in bedtime versus morning BP meds - as expected
#NephSky
#Hypertension
1/
2
56
31
reposted by
Matt Luther, MD MSCI
Jordy Cohen
7 months ago
Aaand itβs official, we have a new antihypertensive class!!!! ππΎπ I like this RCT design in particular because it was open to both uncontrolled not-yet-resistant AND resistant hypertensive patients, opening to door to prescribe it as an earlier line agent
www.nejm.org/doi/full/10....
loading . . .
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
https://www.nejm.org/doi/full/10.1056/NEJMoa2501440
4
45
17
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
7 months ago
The ASIs have arrived
www.nejm.org/doi/full/10....
Aldosterone synthase inhibitors - first one to finish the phase 3 line
#Lorundrostat
#Hypertension
loading . . .
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
https://www.nejm.org/doi/full/10.1056/NEJMoa2501440
3
37
27
How often have you seen Ferric Carboxymaltose cause hypophosphatemia?
@kidneyboy.bsky.social
@hswapnil.medsky.social
@askrenal.bsky.social
#askrenal
pubmed.ncbi.nlm.nih.gov/39659775/
loading . . .
In-depth clinical characterization of intravenous iron infusion-induced hypophosphatemic osteomalacia and its resolution - PubMed
Iron deficiency anemia is treated by iron supplementation. Increasing evidence has shown that the carbohydrate components in iron infusions can cause hypophosphatemia and subsequent osteomalacia due t...
https://pubmed.ncbi.nlm.nih.gov/39659775/
7 months ago
3
14
7
reposted by
Matt Luther, MD MSCI
American Journal of Kidney Diseases
7 months ago
Treatment Effect Heterogeneity in Acute Kidney Injury Incidence Following Intravenous Antihypertensive Administration for Severe Blood Pressure Elevation During Hospitalization
bit.ly/3CEO9n1
#OpenAccess
0
1
1
reposted by
Matt Luther, MD MSCI
David S. Goldfarb MD
7 months ago
We showed a dramatic difference (dramatic for a small sample size!) in the effect of CTD vs HCTZ on urine calcium. That's my preference for stone prevention. RCT with stone outcome needed.
pubmed.ncbi.nlm.nih.gov/40194294/
loading . . .
Effect of Chlorthalidone and Hydrochlorothiazide on Twelve-Hour versus Twenty-Four Hour Urinary Calcium Excretion - PubMed
We conclude that the long-acting and more effective CTD is a preferable agent for stone prevention. Time of administration does not appear to be important, although morning administration may more eff...
https://pubmed.ncbi.nlm.nih.gov/40194294/
0
9
3
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
7 months ago
Retatrutide (GLP, GIP, Glucagon receptor agonist) and albuminuria and GFR changes from phase 2 trial now in
@kireports.bsky.social
Two Ph2 trials, one in T2DM and another in Obesity with about N ~ 300 each uACR reduced in both RCTs (A, B) Much more pronounced when baseline > 30 mg/g (C, D) 1/
1
25
12
reposted by
Matt Luther, MD MSCI
FlexNP
7 months ago
Wait it's wilder. Always check the appendix. They broke down BP reductions by >140 or <140 systolic & >90 or <90 diastolic. Those with HTN saw average reductions of 30mmhg systolic & 15mmHg diastolic for obese patients & 20/10 for diabetics. π€―π€― Also 41% of pts stopped one BP med on 12mg dose
add a skeleton here at some point
2
6
3
reposted by
Matt Luther, MD MSCI
Matthew Kay
7 months ago
behold the CONNECTED SPLATTERPIE kneel before my works, ye mighty, and despair
add a skeleton here at some point
35
398
92
reposted by
Matt Luther, MD MSCI
Heather Gornik
7 months ago
Great pearls by
@jbrianbyrd.bsky.social
in evaluating pts for RDN at
#ACC25
: 1. confirm uncontrolled HTN with out of office measure (Amb BP monitor); 2. trial spironolactone 1st; 3. shared decision making key - care team should include HTN specialists beyond those performing the procedure
#cardiosky
0
8
7
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
8 months ago
From
@spjuraschek.bsky.social
et al in the
@bmj.com
www.bmj.com/content/388/...
Orthostatic
#hypertension
seems bad, but lowering BP intensively also lowers this
#NephSky
loading . . .
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis
Objective To determine the effects of intensive blood pressure treatment on orthostatic hypertension. Design Systematic review and individual participant data meta-analysis. Data sources MEDLINE, Em...
http://www.bmj.com/content/388/bmj-2024-080507.short?rss=1
0
6
2
reposted by
Matt Luther, MD MSCI
Edgar V. Lerma π΅π
8 months ago
Chloride depletion alkalosis (as opposed to what was previously called 'contraction alkalosis')
#Nephpearls
#NephSky
ππΌ
pubmed.ncbi.nlm.nih.gov/22223876/
0
10
4
reposted by
Matt Luther, MD MSCI
Andrew Glazer
8 months ago
π§΅ Iβm excited to share our latest preprint! We studied 252 SCN5A variants found in patients with Brugada Syndrome by automated patch clamp. [1/7]
1
13
6
reposted by
Matt Luther, MD MSCI
Simone Sanna-Cherchi π§¬
8 months ago
Our
#rFSGS
biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures.
#KidneyMonth2025
#RareDisease
#genetics
add a skeleton here at some point
0
12
7
reposted by
Matt Luther, MD MSCI
American Journal of Kidney Diseases
8 months ago
#Quiz
: A man in his 40s with untreated hypertension presented with right-sided neurologic deficits and slurred speech. His hypertension & age prompted investigation for a secondary etiology of his hypertension. What is the differential diagnosis?
bit.ly/3gyO2ie
(FREE)
1
10
6
reposted by
Matt Luther, MD MSCI
American Journal of Hypertension
8 months ago
Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem
academic.oup.com/ajh/article/...
Dr. Wilcox and colleagues
@gumedcenter.bsky.social
0
4
4
reposted by
Matt Luther, MD MSCI
NPR
8 months ago
Dolly Parton's husband, Carl Dean, died on Monday. On Friday at midnight, Parton released the song "If You Hadn't Been There" in his memory.
loading . . .
Dolly Parton pays homage to late husband Carl Dean with 'If You Hadn't Been There'
Dolly Parton's husband, Carl Dean, died on Monday. On Friday at midnight, Parton released the song "If You Hadn't Been There" in his memory.
https://www.npr.org/2025/03/07/g-s1-52637/dolly-parton-husband-carl-dean-if-you-hadnt-been-there
102
7176
964
reposted by
Matt Luther, MD MSCI
Tim Plante, MD MHS
8 months ago
DASH diet with low sodium lowers BP in DM, even when sglt2-i or glp-1 agonists are used!
#epilifestyle25
0
12
2
reposted by
Matt Luther, MD MSCI
Rip Van Cremastericle
8 months ago
me [watching RFK jr bite the head off a freshly killed gila monster]: huh are you doing that for like natural glp-1? RFK jr: for what now?
0
4
1
reposted by
Matt Luther, MD MSCI
ASN Publications
8 months ago
Genetic regulation of plasma sodium concentration is variable and pathways involving the pituitary gland have an important role. There is no evidence of genetic predisposition for the plasma sodium-lowering effect of thiazides.
bit.ly/JASN0622
#ASNJASN
#BasicResearch
0
9
6
reposted by
Matt Luther, MD MSCI
Swapnil Hiremath ππ¨π¦
8 months ago
Very interesting regions indeed
ajkdblog.org/2025/03/01/w...
#NephMadness
#BlueRibbonFail
incoming
2
36
22
reposted by
Matt Luther, MD MSCI
Josh Leisring
9 months ago
I joined Endocrine Society to request a copy. Turns out it is an open link to a surveymonkey site. I checked and they said it was ok to share. Please share your thoughts!
www.surveymonkey.com/r/endopacpg
loading . . .
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Take this survey powered by surveymonkey.com. Create your own surveys for free.
https://www.surveymonkey.com/r/endopacpg
0
4
3
reposted by
Matt Luther, MD MSCI
Endocrine Society
9 months ago
Primary Aldosteronism Guideline Now Available for Open Comment | Society members are invited to review and provide feedback for our new development of a new guideline, which was provided to them via email. The comment period will close on Tuesday, March 4.
#aldosteronism
#endocrinology
#EndoSky
1
5
3
reposted by
Matt Luther, MD MSCI
Joel Topf
9 months ago
Do you know why Bluesky limits you to 4 images? Because that is enough to get the entire manuscript by O MΓΌller-Plathe in a single post
pubmed.ncbi.nlm.nih.gov/3126258/
This is the reference from Chapter 17 of Burton Rose
0
8
2
reposted by
Matt Luther, MD MSCI
Edgar V. Lerma π΅π
9 months ago
Check out the latest Channel Your Enthusiasm Podcast π§ covering Chapter 17: Introduction to Simple and Mixed Acid Base Disorders
#Nephpearls
This discussion brings back memories of the Davenport Diagram π§ͺ ππΌ
www.rosebook.club/episodes/202...
3
19
10
reposted by
Matt Luther, MD MSCI
depths of wikipedia
9 months ago
195
14260
2972
reposted by
Matt Luther, MD MSCI
European Journal of Endocrinology
9 months ago
Mild autonomous
#cortisol
secretion in patients with aldosterone-producing adenoma and risk for cardiac remodeling and diastolic dysfunction by Cheng-Hsuan Tsai et al EJE Vol 192, Issue 1, January 2025 Full paper π
doi.org/10.1093/ejen...
ESE Members via π
my.ese-hormones.org
0
6
6
reposted by
Matt Luther, MD MSCI
Nashville Severe Weather
9 months ago
8:42 pm, Just to give an idea of ETAs, if the storm crossing the TN River keeps its current speed, it would get to Davidson Co about 10pm. I'd be where you're gonna be by 9:30 ish.
2
64
3
reposted by
Matt Luther, MD MSCI
Sarah Melville
9 months ago
Save the Date!, ππ€πππ May 29-30, 2025! Hypertension Canada (virtual) conference! Link to register:
hypertension.ca/2025-virtual...
2025
#Hypertension
Canada clinical guidelines led by Dr. Hundemer & Dr.
@goupilremi.bsky.social
+ soo coool that Dr.
@drjmluther.bsky.social
will be presenting!π€π
loading . . .
2025 Virtual Congress β Hypertension Canada | For Healthcare Professionals
https://hypertension.ca/2025-virtual-congress/
1
10
6
reposted by
Matt Luther, MD MSCI
Bad Medical Takes
9 months ago
14
282
16
reposted by
Matt Luther, MD MSCI
Helen Branswell π¨π¦
9 months ago
Moving defense of childhood
#vaccines
by Vanderbilt vaccine expert Kathy Edwards in JAMA. Stunning that so many people fear the tools that prevent children from dying and being maimed, rather than the pathogens that resurge when vaccine use declines.
jamanetwork.com/journals/jam...
loading . . .
Reflections on the Successes of Pediatric Vaccines
This Viewpoint discusses the importance of early and continued vaccine use in the US.
https://jamanetwork.com/journals/jama/fullarticle/2830143
7
400
176
reposted by
Matt Luther, MD MSCI
Dr Lindsey Fitzharris
9 months ago
THE MERITS OF OUR COCAINE - a pharmaceutical advert from 1907. A "first-class, thoroughly reliable preparation" that has "been fully recognized by the majority of physicians, surgeons and chemists."
23
255
44
reposted by
Matt Luther, MD MSCI
Joseph Flynn, MD
9 months ago
Thick skin and thicker arteries: case report on a rare cause of hypertension
link.springer.com/article/10.1...
#hypertension
#nephsky
1
11
1
reposted by
Matt Luther, MD MSCI
NEJM.org
9 months ago
New in the January 30, 2025, issue of NEJM: Tirzepatide for Heart Failure and Obesity (SUMMIT trial)
nej.md/4hRGaTY
Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial)
nej.md/3XllHys
Lentiviral Gene Therapy for Hemophilia A
nej.md/3Vk5xUA
#MedSky
1
20
6
reposted by
Matt Luther, MD MSCI
American Journal of Kidney Diseases
9 months ago
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of ESKD and Death in ADPKD: Long-Term Follow-Up of the HALT-PKD Trials
https://bit.ly/4g6t82A
(FREE)
0
6
3
reposted by
Matt Luther, MD MSCI
Simone Sanna-Cherchi π§¬
9 months ago
"Why study genetic diseases when you cannot treat them?" We've seen these comments from grants' reviewers way too many times Wrong! Genetics offers a myriad of possibilities for targeted treatments: here is one and it's happening now!
@asnpublications.bsky.social
journals.lww.com/jasn/fulltex...
loading . . .
Treating the Untreatable: Antisense Oligonucleotides as an... : Journal of the American Society of Nephrology
An abstract is unavailable.
https://journals.lww.com/jasn/fulltext/2024/12000/treating_the_untreatable__antisense.19.aspx
0
10
4
This should make my pharmacist's job a little easier to get approval.
add a skeleton here at some point
10 months ago
1
1
0
reposted by
Matt Luther, MD MSCI
Dr Lindsey Fitzharris
10 months ago
Welcome, newbies! βOne Night Cough Syrupβ from the 1930s contained cannabis, morphine, chloroform, & alcohol. In 1934, the FDA ruled that claims of the cough syrup's therapeutic properties were misleading. Remaining stock was destroyed. Enjoy medical history? Come along and join me!
42
540
79
reposted by
Matt Luther, MD MSCI
Jeremy Berg
10 months ago
In the present discussions about NIH and the need for reform, two recurring points I am seeing are: (1) NIH doesn't fund truly high impact research (2) NIH needs to experiment with alternative approaches to peer review, particularly for high risk-high impact research 1/n
6
140
66
Load more
feeds!
log in